Vertex Pharmaceuticals Inc. buy Scotiabank
Start price
13.02.26
/
50%
€416.25
Target price
13.02.27
-
Performance (%)
-2.23%
Price
22:26
€406.95
Summary
This prediction is currently active. With a performance of -2.23%, the BUY prediction for Vertex Pharmaceuticals Inc. by Scotiabank is down slightly. This prediction currently runs until 13.02.27. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | 2.518% |
| iShares Core DAX® | 0.048% |
| iShares Nasdaq 100 | 1.601% |
| iShares Nikkei 225® | 3.057% |
| iShares S&P 500 | 0.820% |
Comments by Scotiabank for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Scotiabank for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€377.95
14.11.25
14.11.25
-
14.11.26
14.11.26
7.67%
22:26
22:26
